Functional Injectable Hydrogel for Bone Regeneration: Regulation of the circSRPK1/miR-320a Axis and Targeting Multiple Osteogenic Pathways via CDH2 and Osterix Genes

Abstract

Hydrogels loaded with microRNA (miRNA) have shown promise in bone-defect repair. Here, we present the first report of miRNA-loaded hydrogels containing bioactivities to treat steroid-induced osteonecrosis of the femoral head (SONFH), based on the mechanism of competing endogenous RNAs. Transcriptome sequencing of human bone marrow mesenchymal stem cells (HBMSCs) extracted from the proximal femoral bone marrow and subsequent functional assays revealed that the circSRPK1/miR-320a axis promotes HBMSCs osteogenic differentiation. By incorporating antagomir-320a (a miR-320a inhibitor) encapsulated in liposomes into injectable hyaluronic acid (HA) hydrogels, we constructed an injectable hydrogel, HA@antagomir-320a. This hydrogel demonstrated exceptional osteogenic properties, targeting multiple osteogenic pathways via CDH2 and Osterix and exhibited excellent in vitro biocompatibility. In vivo, it substantially enhanced bone formation in the osteonecrotic area of the femoral head. This injectable HA@antagomir-320a hydrogel, which exhibited exceptional biocompatibility and osteogenic properties in vivo and in vitro, offers a promising and minimally invasive solution for the treatment of SONFH.

Keywords

bone regeneration / CDH2 and Osterix / circSRPK1/miR-320a axis / HA@antagomir-320a hydrogel / osteonecrosis of femoral head

References

[1] L. Cui, Q. Zhuang, J. Lin, et al., “Multicentric Epidemiologic Study on Six Thousand Three Hundred and Ninety Five Cases of Femoral Head Osteonecrosis in China,” International Orthopaedics 40, no. 2 (2016): 267–276.

[2] Q. Xu, H. Chen, S. Chen, et al., “Development and Validation of a Nomogram for Predicting the Probability of Nontraumatic Osteonecrosis of the Femoral Head in Chinese Population,” Scientific Reports 10, no. 1 (2020): 20660.

[3] Y. Osawa, T. Seki, Y. Takegami, K. Makida, S. Ochiai, and S. Imagama, “Collapse Progression or Cessation Affects the Natural History of Contralateral Osteonecrosis of the Femoral Head,” The Journal of Arthroplasty 36, no. 12 (2021): 3839–3844.

[4] L. Wang, L. Zhu, Z. Wang, et al., “Development of a Centrally Vascularized Tissue Engineering Bone Graft With the Unique Core-Shell Composite Structure for Large Femoral Bone Defect Treatment,” Biomaterials 175 (2018): 441–60.

[5] Y. Zheng, Z. Zheng, K. Zhang, and P. Zhu, “Osteonecrosis in Systemic Lupus Erythematosus: Systematic Insight From the Epidemiology, Pathogenesis, Diagnosis and Management,” Autoimmunity Reviews 21, no. 2 (2022): 102992.

[6] F. Sadile, A. Bernasconi, F. Carbone, F. Lintz, and G. Mansueto, “Histological Fibrosis May Predict the Failure of Core Decompression in the Treatment of Osteonecrosis of the Femoral Head,” International Journal of Surgery 44 (2017): 303–308.

[7] Q. Zhu, Y. Tang, T. Zhou, et al., “Exosomes Derived From Mesenchymal Stromal Cells Promote Bone Regeneration by Delivering miR-182-5P-Inhibitor,” Pharmacological Research 192 (2023): 106798.

[8] S. Stevenson and M. Horowitz, “The Response to Bone Allografts,” The Journal of Bone & Joint Surgery 74, no. 6 (1992): 939–950.

[9] R. J. Molenaars, B. J. A. Schoolmeesters, J. Viveen, B. The, and D. Eygendaal, “There Is a Role for Allografts in Reconstructive Surgery of the Elbow and Forearm,” Knee Surgery, Sports Traumatology, Arthroscopy 27, no. 6 (2019): 1840–1846.

[10] Y. Han, L. Cao, G. Li, F. Zhou, L. Bai, and J. Su, “Harnessing Nucleic Acids Nanotechnology for Bone/Cartilage Regeneration,” Small 19, no. 37 (2023): e2301996.

[11] W. T. Oh, Y. S. Yang, J. Xie, et al., “WNT-Modulating Gene Silencers as a Gene Therapy for Osteoporosis, Bone Fracture, and Critical-Size. Bone Defects,” Molecular Therapy 31, no. 2 (2023): 435–453.

[12] G. Wang, Z. Lv, T. Wang, et al., “Surface Functionalization of Hydroxyapatite Scaffolds With MgAlEu-LDH Nanosheets for High-Performance Bone Regeneration,” Advancement of Science 10, no. 1 (2022): e2204234.

[13] Z. Lv, T. Hu, Y. Bian, et al., “A MgFe-LDH Nanosheet-Incorporated Smart Thermo-Responsive Hydrogel With Controllable Growth Factor Releasing Capability for Bone Regeneration,” Advanced Materials 35, no. 5 (2023): e2206545.

[14] S. Vermeulen, Z. Tahmasebi Birgani, and P. Habibovic, “Biomaterial-Induced Pathway Modulation for Bone Regeneration,” Biomaterials 283 (2022): 121431.

[15] Y. Wang, S. Shen, T. Hu, et al., “Layered Double Hydroxide Modified Bone Cement Promoting Osseointegration via Multiple Osteogenic Signal Pathways,” ACS Nano 15, no. 6 (2021): 9732–9745.

[16] V. Kumaravel, K. M. Nair, S. Mathew, et al., “Antimicrobial TiO₂ Nanocomposite Coatings for Surfaces, Dental and Orthopaedic Implants,” Chemical Engineering Journal 416 (2021): 129071.

[17] L. Ou, Y. Lan, Z. Feng, et al., “Functionalization of SF/HAP Scaffold With GO-PEI-miRNA Inhibitor Complexes to Enhance Bone Regeneration Through Activating Transcription Factor 4,” Theranostics 9, no. 15 (2019): 4525–4541.

[18] D. S. Yoon, Y. Choi, K. M. Lee, et al., “Downregulation of the RNA-Binding Protein PUM2 Facilitates MSC-Driven Bone Regeneration and Prevents OVX-Induced Bone Loss,” Journal of Biomedical Science 30, no. 1 (2023): 26.

[19] N. T. Kieu Nguyen, Y. Tu, H. S. Lee, et al., “Split dCas12a Activator for lncRNA H19 Activation to Enhance BMSC Differentiation and Promote Calvarial Bone Healing,” Biomaterials 297 (2023): 122106.

[20] Z. Zhang, P. Ding, Y. Meng, et al., “Rational Polyelectrolyte Nanoparticles Endow Preosteoclast-Targeted siRNA Transfection for Anabolic Therapy of Osteoporosis,” Science Advances 9, no. 10 (2023): eade7379.

[21] S. Liu, W. Liu, Q. Yang, et al., “Non-Coding-RNA-Activated Core/Chitosan Shell Nanounits Coated With Polyetheretherketone for Promoting Bone Regeneration and Osseointegration via Osteoimmunology,” ACS Applied Materials & Interfaces 15, no. 10 (2023): 12653–12668.

[22] Y. S. Yang, J. M. Kim, J. Xie, et al., “Suppression of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva Using AAV Gene Delivery,” Nature Communications 13, no. 1 (2022): 6175.

[23] Y. Cui, Z. Li, Y. Guo, et al., “Bioinspired Nanovesicles Convert the Skeletal Endothelium-Associated Secretory Phenotype to Treat Osteoporosis,” ACS Nano 16, no. 7 (2022): 11076–11091.

[24] H. Liu, Y. Dong, X. Feng, et al., “miR-34a Promotes Bone Regeneration in Irradiated Bone Defects by Enhancing Osteoblastic Differentiation of Mesenchymal Stromal Cells in Rats,” Stem Cell Research & Therapy 10, no. 1 (2019): 180.

[25] Z. Hu, L. Zhang, H. Wang, et al., “Targeted Silencing of miRNA-132-3p Expression Rescues Disuse Osteopenia by Promoting Mesenchymal Stem Cell Osteogenic Differentiation and Osteogenesis in Mice,” Stem Cell Research & Therapy 11, no. 1 (2020): 58.

[26] J. H. Hwang, Y. S. Park, H. S. Kim, et al., “Yam-Derived Exosome-Like Nanovesicles Stimulate Osteoblast Formation and Prevent Osteoporosis in Mice,” Journal of Controlled Release 355 (2023): 184–198.

[27] Y. Lan, H. Xie, Q. Jin, et al., “Extracellular Vesicles Derived From Neural EGFL-Like 1-modified Mesenchymal Stem Cells Improve Acellular Bone Regeneration via the miR-25-5p-SMAD2 Signaling Axis,” Bioactive Materials 17 (2022): 457–470.

[28] A. Liu, D. Lin, H. Zhao, et al., “Optimized BMSC-Derived Osteoinductive Exosomes Immobilized in Hierarchical Scaffold via Lyophilization for Bone Repair Through Bmpr2/Acvr2b Competitive Receptor-Activated Smad Pathway,” Biomaterials 272 (2021): 120718.

[29] J. Ning, Y. Ye, D. Bu, et al., “Imbalance of TGF-β1/BMP-7 Pathways Induced by M2-polarized Macrophages Promotes Hepatocellular Carcinoma Aggressiveness,” Molecular Therapy 29, no. 6 (2021): 2067–2087.

[30] C. Yu, L. Chen, W. Zhou, et al., “Injectable Bacteria-Sensitive Hydrogel Promotes Repair of Infected Fractures via Sustained Release of miRNA Antagonist,” ACS Applied Materials & Interfaces 14, no. 30 (2022): 34427–34442.

[31] Y. Xie, J. Zhou, L. Tian, et al., “miR-196b-5p Regulates Osteoblast and Osteoclast Differentiation and Bone Homeostasis by Targeting SEMA3A,” Journal of Bone and Mineral Research 38, no. 8 (2023): 1175–1191.

[32] Z. Stavre, J. M. Kim, Y. S. Yang, et al., “Schnurri-3 Inhibition Suppresses Bone and Joint Damage in Models of Rheumatoid Arthritis,” Proceedings of the National Academy of Sciences of the United States of America 120, no. 19 (2023): e2218019120.

[33] Y. Wang, Y. Wu, B. Zhang, et al., “Repair of Degenerative Nucleus Pulposus by Polyphenol Nanosphere-Encapsulated Hydrogel Gene Delivery System,” Biomaterials 298 (2023): 122132.

[34] Q. Cui, J. Xing, M. Yu, et al., “Mmu-miR-185 Depletion Promotes Osteogenic Differentiation and Suppresses Bone Loss in Osteoporosis Through the Bgn-Mediated BMP/Smad Pathway,” Cell Death & Disease 10, no. 3 (2019): 172.

[35] X. Wang, M. B. Liisberg, G. L. Nolt, et al., “DNA-AgNC Loaded Liposomes for Measuring Cerebral Blood Flow Using Two-Photon Fluorescence Correlation Spectroscopy,” ACS Nano 17, no. 13 (2023): 12862–12874.

[36] J. Zhang, K. Ji, Y. Ning, et al., “Biological Hyperthermia-Inducing Nanoparticles for Specific Remodeling of the Extracellular Matrix Microenvironment Enhance Pro-Apoptotic Therapy in Fibrosis,” ACS Nano 17, no. 11 (2023): 10113–10128.

[37] A. Yan, X. Chen, J. He, et al., “Phosphorothioated DNA Engineered Liposomes as a General Platform for Stimuli-Responsive Cell-Specific Intracellular Delivery and Genome Editing,” Angewandte Chemie International Edition in English 62, no. 25 (2023): e202303973.

[38] Q. Li, W. Hu, Q. Huang, et al., “MiR146a-Loaded Engineered Exosomes Released From Silk Fibroin Patch Promote Diabetic Wound Healing by Targeting IRAK1,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 62.

[39] Z. Luo, B. Qi, Y. Sun, et al., “Engineering Bioactive M2 Macrophage-Polarized, Anti-Inflammatory, Mirna-Based Liposome. for Functional Muscle Repair: From Exosomal Mechanisms to Biomaterials,” Small 18, no. 34 (2022): e2201957.

[40] Q. Liu, Y. Zhu, W. Zhu, G. Zhang, Y. P. Yang, and C. Zhao, “The Role of MicroRNAs in Tendon Injury, Repair, and Related Tissue Engineering,” Biomaterials 277 (2021): 121083.

[41] Y. He, M. Sun, J. Wang, et al., “Chondroitin Sulfate Microspheres Anchored With Drug-Loaded Liposomes Play a Dual Antioxidant Role in the Treatment of Osteoarthritis,” Acta Biomaterialia 151 (2022): 512–527.

[42] Y. Lei, X. Wang, J. Liao, et al., “Shear-Responsive Boundary-Lubricated Hydrogels Attenuate Osteoarthritis,” Bioactive Materials 16 (2022): 472–484.

[43] C. Gao, K. Cheng, Y. Li, et al., “Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy,” Nano Letters 22, no. 22 (2022): 8801–8809.

[44] Y. Luo, M. Xiao, B. Almaqrami, et al., “Regenerated Silk Fibroin Based on Small Aperture Scaffolds and Marginal Sealing Hydrogel for Osteochondral Defect Repair,” Biomaterials Research 27, no. 1 (2023): 50.

[45] Z. Wang, Y. Zhang, Y. Yin, et al., “High-Strength and Injectable Supramolecular Hydrogel Self-Assembled by Monomeric Nucleoside for Tooth-Extraction Wound Healing,” Advanced Materials 34, no. 13 (2022): e2108300.

[46] Y. Liang, M. Li, Y. Yang, L. Qiao, H. Xu, and B. Guo, “pH/Glucose Dual Responsive Metformin Release Hydrogel Dressings With Adhesion and Self-Healing via Dual-Dynamic Bonding for Athletic Diabetic Foot Wound Healing,” ACS Nano 16, no. 2 (2022): 3194–3207.

[47] Y. Li, L. Li, M. Wang, et al., “O-alg-THAM/gel Hydrogels Functionalized With Engineered Microspheres Based on Mesenchymal Stem Cell Secretion Recruit Endogenous Stem Cells for Cartilage Repair,” Bioactive Materials 28 (2023): 255–272.

[48] L. Chen, M. Peng, J. Zhou, et al., “Supramolecular Photothermal Cascade Nano-Reactor Enables Photothermal Effect, Cascade Reaction, and In Situ Hydrogelation for Biofilm-Associated Tooth-Extraction Wound Healing,” Advanced Materials 35, no. 31 (2023): e2301664.

[49] Y. Ju, Y. Hu, P. Yang, X. Xie, and B. Fang, “Extracellular Vesicle-Loaded Hydrogels for Tissue Repair and Regeneration,” Materials Today Bio 18 (2023): 100522.

[50] X. Sun, W. Song, L. Teng, et al., “MiRNA 24-3p-rich Exosomes Functionalized DEGMA-Modified Hyaluronic Acid Hydrogels for Corneal Epithelial Healing,” Bioactive Materials 25 (2023): 640–656.

[51] J. Zhu, S. Yang, Y. Qi, et al., “Stem Cell-Homing Hydrogel-Based miR-29b-5p Delivery Promotes Cartilage Regeneration by Suppressing Senescence in an Osteoarthritis Rat Model,” Science Advances 8, no. 13 (2022): eabk0011.

[52] T. Pan, W. Song, H. Xin, et al., “MicroRNA-Activated Hydrogel Scaffold Generated by 3D Printing Accelerates Bone Regeneration,” Bioactive Materials 10 (2022): 1–14.

[53] J. E. Frith, G. D. Kusuma, J. Carthew, et al., “Mechanically-Sensitive miRNAs Bias Human Mesenchymal Stem Cell Fate via Mtor Signalling,” Nature Communications 9, no. 1 (2018): 257.

[54] M. Gan, Q. Zhou, J. Ge, et al., “Precise In-Situ Release of MicroRNA From an Injectable Hydrogel Induces Bone Regeneration,” Acta Biomaterialia 135 (2021): 289–303.

[55] C. Cai, X. Zhang, Y. Li, et al., “Self-Healing Hydrogel Embodied With Macrophage-Regulation and Responsive-Gene-Silencing Properties for Synergistic Prevention of Peritendinous Adhesion,” Advanced Materials 34, no. 5 (2022): e2106564.

[56] Y. Xu, G. Lu, M. Chen, et al., “Redox and pH Dual-Responsive Injectable Hyaluronan Hydrogels With Shape-Recovery and Self-Healing Properties for Protein and Cell Delivery,” Carbohydrate Polymers 250 (2020): 116979.

[57] Y. Wang, W. Zhu, K. Xiao, et al., “Self-Healing and Injectable Hybrid Hydrogel for Bone Regeneration of Femoral Head Necrosis and Defect,” Biochemical and Biophysical Research Communications 508, no. 1 (2019): 25–30.

[58] B. Koh, F. H. Ab Rahman, N. A. Matlan, et al., “Potential Role of Dental Pulp Stem Cells Conditioned Medium for Odontoblastic Differentiation,” Biological Research 55, no. 1 (2022): 11.

[59] K. Futrega, K. Atkinson, W. B. Lott, and M. R. Doran, “Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion,” Tissue Engineering Part C: Methods 23, no. 4 (2017): 200–218.

[60] Y. Wu, Y. Zhang, X. Zheng, et al., “Circular RNA circCORO1C Promotes Laryngeal Squamous Cell Carcinoma Progression by Modulating the let-7c-5p/PBX3 Axis,” Molecular Cancer 19, no. 1 (2020): 99.

[61] D. Li, J. Zhang, J. Yang, et al., “CircMTO1 Suppresses Hepatocellular Carcinoma Progression via the miR-541-5p/ZIC1 by Regulating Wnt/Beta-Catenin Signaling Pathway and Epithelial-to-Mesenchymal Transition,” Cell Death & Disease 13, no. 1 (2021): 12.

[62] D. Hamam, D. Ali, R. Vishnubalaji, et al., “MicroRNA-320/RUNX2 Axis Regulates Adipocytic Differentiation of Human Mesenchymal (Skeletal) Stem Cells,” Cell Death & Disease 5, no. 10 (2014): e1499.

[63] C. G. Wang, Y. H. Hu, S. L. Su, and D. Zhong, “LncRNA DANCR and miR-320a Suppressed Osteogenic Differentiation in Osteoporosis by Directly Inhibiting the Wnt/β-Catenin Signaling Pathway,” Experimental & Molecular Medicine 52, no. 8 (2020): 1310–1325.

[64] Z. Yan, T. Sun, W. Tan, et al., “Magnetic Field Boosts the Transmembrane Transport Efficiency of Magnesium Ions From PLLA Bone Scaffold,” Small 19, no. 40 (2023): e2301426.

[65] G. Zhong, S. Su, J. Li, et al., “Activation of Piezo1 Promotes Osteogenic Differentiation of Aortic Valve Interstitial Cell Through YAP-Dependent Glutaminolysis,” Science Advances 9, no. 22 (2023): eadg0478.

[66] G. M. Awale, M. A. Barajaa, H. M. Kan, et al., “Regenerative Engineering of Long Bones Using the Small Molecule Forskolin,” Proceedings of the National Academy of Sciences of the United States of America 120, no. 22 (2023): e2219756120.

[67] A. Sethi, J. G. Ruby, M. A. Veras, N. Telis, and E. Melamud, “Genetics Implicates Overactive Osteogenesis in the Development of Diffuse Idiopathic Skeletal Hyperostosis,” Nature Communications 14, no. 1 (2023): 2644.

[68] N. Zioni, A. A. Bercovich, N. Chapal-Ilani, et al., “Inflammatory Signals From Fatty Bone Marrow Support DNMT3A Driven Clonal Hematopoiesis,” Nature Communications 14, no. 1 (2023): 2070.

[69] X. Yang, G. Liu, L. Peng, et al., “Highly Efficient Self-Healable and Dual Responsive Cellulose-Based Hydrogels for Controlled Release and 3D Cell Culture,” Advanced Functional Materials 27, no. 40 (2017): 1703174.

[70] T. Xu, X. Hou, Y. Han, et al, “Fused Indacene Dimers,” Angewandte Chemie-International Edition in English 62, no. 38 (2023): e202304937.

[71] H. Zhuo, Y. Zhao, X. Cheng, et al., “Tumor Endothelial Cell-Derived Cadherin-2 Promotes Angiogenesis and Has Prognostic Significance for Lung Adenocarcinoma,” Molecular Cancer 18, no. 1 (2019): 34.

[72] Z. Zhou, H. Wang, X. Zhang, et al., “Defective Autophagy Contributes to Endometrial Epithelial-Mesenchymal Transition in Intrauterine Adhesions,” Autophagy 18, no. 10 (2022): 2427–2442.

[73] F. Pontis, L. Roz, M. Mensah, et al., “Circulating Extracellular Vesicles From Individuals at High-Risk of Lung Cancer Induce Pro-Tumorigenic Conversion of Stromal Cells Through Transfer of miR-126 and miR-320,” Journal of Experimental & Clinical Cancer Research 40, no. 1 (2021): 237.

[74] H. Zhu, B. Zhai, C. He, et al., “LncRNA TTN-AS1 Promotes the Progression of Cholangiocarcinoma via the miR-320a/Neuropilin-1 Axis,” Cell Death & Disease 11, no. 8 (2020): 637.

[75] Y. L. Lo, H. C. Lin, and W. H. Tseng, “Tumor pH-Functionalized and Charge-Tunable Nanoparticles for the Nucleus/Cytoplasm-Directed Delivery of Oxaliplatin and miRNA in the Treatment of Head and Neck Cancer,” Acta Biomaterialia 153 (2022): 465–480.

[76] O. A. Sukocheva, J. Liu, M. E. Neganova, et al., “Perspectives of Using MicroRNA-Loaded Nanocarriers for Epigenetic Reprogramming of Drug Resistant Colorectal Cancers,” Seminars in Cancer Biology 86, no. Pt 2 (2022): 358–375.

[77] X. Gao, Z. Wan, M. Wei, et al., “Chronic Myelogenous Leukemia Cells Remodel the Bone Marrow Niche via Exosome-Mediated Transfer of miR-320,” Theranostics 9, no. 19 (2019): 5642–5656.

[78] D. Rudolph, N. Redinger, K. Schwarz, et al., “Amorphous Drug Nanoparticles for Inhalation Therapy of Multidrug-Resistant Tuberculosis,” ACS Nano 17, no. 10 (2023): 9478–9486.

[79] J. Sun, Z. Liu, H. Yao, et al., “Azide-Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy,” Advanced Materials 35, no. 29 (2023): e2207733.

RIGHTS & PERMISSIONS

2025 The Author(s). SmartMat published by Tianjin University and John Wiley & Sons Australia, Ltd.